Halozyme Therapeutics (HALO): Q1 EPS of $0.14 beats by $0.25. Revenue of $7.4M (-1.3% Y/Y)...

|About: Halozyme Therapeutics, Inc. (HALO)|By:, SA News Editor
Halozyme Therapeutics (HALO): Q1 EPS of $0.14 beats by $0.25. Revenue of $7.4M (-1.3% Y/Y) in-line. (PR)